November 2022 FDA Recall Drug by Par Formulations Private Limited
D-0061-2023 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Par Formulations Private Limited on November 10, 2022 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0061-2023

Reason for Recall
Failed Impurities/Degradation Specifications
Initiated
11-10-2022
Reported
11-23-2022
Quantity
218 bottles/100 capsules per bottle

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Par Formulations Private Limited
Nationwide within the United States
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01

Batch or Lot Expiration Information

Lot# : 15429401, Exp. Date 08/2023